Recent insider trends for OncoSec Medical Incorporated (NASDAQ:ONCS) have caught the attention of investors. Insider activity is often a strong indicator of future performance in a stock, and if the data on ONCS is anything to go by, investors should pay attention.
Institutions own 09.10% of OncoSec Medical Incorporated (ONCS)’s shares. The total value of these holdings, in millions, is $2. Among active positions in the latest quarter, 8 holders increased their positions by a total of 326109 shares, 9 holders decreased the positions by a total of 251589 shares, and 8 holders held their positions. This works out to a net increase in ownership of 74520 shares, and suggests that institutions are feeling bullish about the stock.
Among new and sold out positions, 4 holders initiated new positions by a total of 82588 shares and 3 holders exited their positions by a total of 66605 shares. This nets out to an increase of 15983 shares and is a bullish sign for ONCS.
In the last three months, insiders executed a total of 2 trades. 2 of these were buys. Insider ownership increased by a total of 6000 shares, which suggests that ONCS’s key executives are feeling more optimistic about the outlook for the stock. The data from the past twelve months tells a similar story: insiders executed 4 buys, and ownership increased by a net of 12000 shares.
Short interest, or the number of a stock’s tradable shares currently being shorted, is another metric investors use to get a pulse on sentiment. OncoSec Medical Incorporated (NASDAQ:ONCS)’s short interest is 645400 shares, or 3.41% of the float. This represents a decrease of -22% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.
Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that ONCS is a Strong buy, which implies that ONCS is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bullish. Technical indicators (also) suggest that OncoSec Medical Incorporated (NASDAQ:ONCS) is undervalued.